National
National news in brief
Embattled minister steps down from anti-gay group & more
Embattled minister steps down from anti-gay group
SALT LAKE CITY — In the wake of allegations that he had sexual contact with two male escorts, an anti-gay organization’s board member is resigning his membership with the group.
But George Rekers said in a statement published Tuesday to the National Association for Research & Therapy of Homosexuality’s web site that he is not gay “and never have been.”
“I am immediately resigning my membership in NARTH to allow myself the time necessary to fight the false media reports that have been made against me,” he said. “With the assistance of a defamation attorney, I will fight these false reports because I have not engaged in any homosexual behavior whatsoever. I am not gay and never have been.”
Rekers drew international media attention — and jabs from television comics — last week after the Baptist minister was photographed at Miami International Airport with a man he allegedly met through Rentboy.com, a gay web site.
The BBC reported that Rekers said he hired the man as a travel assistant and “was not involved in any illegal or sexual behavior.”
Various outlets later reported the man Rekers hired said the two had sexual contact. A second man reportedly came forward May 7, claiming he had a sexual encounter with Rekers in 1992.
In the statement published Tuesday on its web site, NARTH noted that it “has accepted Dr. Rekers’ resignation and would hope that the legal process will sufficiently clarify the questions that have arisen in this unfortunate situation.”
Gay couples ask judge to toss Defense of Marriage Act
BOSTON — Seven gay couples and three widowers who married in Massachusetts after it became the first state in the nation to legalize same-sex marriage went to court May 6 to challenge the constitutionality of a federal law that defines marriage as a union between a man and a woman.
The couples filed a lawsuit last year, arguing that the Defense of Marriage Act is discriminatory because it denies same-sex couples access to federal benefits given to heterosexual couples. U.S. District Judge Joseph Tauro held the first hearing in the case last week.
The Associated Press reported that the couples include a Social Security Administration retiree who was denied health insurance for his spouse; three widowers who were denied death benefits for funeral expenses; and couples who have paid more in taxes because they are not allowed to file joint returns.
Mary Bonauto, an attorney with Gay & Lesbian Advocates & Defenders, said the 1996 law, known as DOMA, got the federal government involved in regulating marriage, something it had left to the states for more than 200 years. She said the law denies gay couples access to more than 1,000 federal programs and legal protections in which marriage is a factor.
“What DOMA does is negate their marital status,” Bonauto argued during the hearing, according to the Associated Press.
The law was enacted by Congress in 1996 when it appeared Hawaii would soon legalize same-sex marriage and opponents worried that other states would be forced to recognize such marriages. The lawsuit challenges only the portion of the law that prevents the federal government from affording Social Security and other benefits to same-sex couples.
Since then, five states and the District of Columbia have legalized gay marriage.
W. Scott Simpson, a Justice Department lawyer, said the Obama administration is opposed to the law, but the department has an obligation to defend the constitutionality of laws passed by Congress.
“This presidential administration disagrees with DOMA as a matter of policy and would like to see it repealed, but that does not affect the statute’s constitutionality,” Simpson said.
Simpson said the law does not interfere with the rights of individual states to “experiment in the area of marriage, but that should not dictate how the federal government applies federal law.”
Tauro did not indicate when he would rule on the government’s motion to dismiss the lawsuit and the couples’ request to declare the law unconstitutional.
Pope: Church’s own sins to blame in sex scandal
LISBON, Portugal — In his most thorough admission of the church’s guilt in the clerical sex abuse scandal, Pope Benedict XVI said Tuesday the greatest persecution of the institution “is born from the sins within the church,” and not from a campaign by outsiders.
The Associated Press reported the pontiff said the Catholic church has always been tormented by problems of its own making — a tendency that is being witnessed today “in a truly terrifying way.”
“The church needs to profoundly relearn penitence, accept purification, learn forgiveness but also justice,” the Associated Press quoted him as saying. “Forgiveness cannot substitute justice.”
Benedict was responding to journalists’ questions, submitted in advance, aboard the papal plane as he flew to Portugal for a four-day visit.
In a shift from the Vatican’s initial claim that the church was the victim of a campaign by the media and abortion rights and pro-gay marriage groups, Benedict said: “The greatest persecution of the church doesn’t come from enemies on the outside but is born from the sins within the church.”
Previously, he has taken to task the abusers themselves and, in the case of Ireland, the bishops who failed to stop them.
Benedict has promised that the church would take action to protect children and make abusive priests face justice. He has started cleaning house, accepting the resignations of a few bishops who either admitted they molested youngsters or covered up for priests who did.
Critics are demanding more. They recall that while Benedict has scolded his church and accepted some bishops’ resignations, none of them has been actively punished or defrocked, even those who admitted molesting children.
“Many are tiring of hearing about his ‘strong comments.’ They want to see strong action,” said David Clohessy, director of the main U.S. victims’ group, the Survivors Network of those Abused by Priests.
Portugal has reported no cases of abuse, and the pontiff was expected to address other issues during his appearances here, especially the neglect of Christian values.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
